Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

The move marks another escalation of the battle between Lilly and Novo Nordisk in the fast-growing obesity drugs market, where Zepbound is in a head-to-head contest with the latter's Wegovy ...

There's no shortage of companies trying to break into the category, however, and the search is on for newer products that can improve on the weight loss achieved by Wegovy and Zepbound.

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

For more than a year after Zepbound hit the market in 2022 ... This week, the FDA also removed Ozempic and Wegovy from the drug shortage list. The agency gave compounding pharmacies a 30- to 60-day ...